Balancing Scientific Innovation & Operational Efficiency: Key Challenges & Solutions for Biopharma
- Regulatory and data complexity – Strict GMP compliance demands complete, auditable asset records, but data is often scattered across multiple systems, slowing decision-making and risking audit failures
- Operational inefficiency – Reactive maintenance, underutilized equipment, and lack of predictive tools lead to costly downtime, wasted capacity, and overspending on service contracts
- Scalability and security risks – Rapid scale-up, M&A Activity, and IOT-connected equipment create challenges in asset reallocation, cybersecurity, and safeguarding production continuity